(NASDAQ: AXGN) Axogen's forecast annual revenue growth rate of 11.84% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Axogen's revenue in 2024 is $159,012,000.On average, 2 Wall Street analysts forecast AXGN's revenue for 2024 to be $7,736,078,346, with the lowest AXGN revenue forecast at $7,733,918,034, and the highest AXGN revenue forecast at $7,738,238,659. On average, 2 Wall Street analysts forecast AXGN's revenue for 2025 to be $8,682,295,134, with the lowest AXGN revenue forecast at $8,654,211,074, and the highest AXGN revenue forecast at $8,710,379,194.
In 2026, AXGN is forecast to generate $9,606,908,798 in revenue, with the lowest revenue forecast at $9,604,748,486 and the highest revenue forecast at $9,609,069,110.